Aceprometazine

This classification denotes an antidepressant agent with the molecular formula C19H22N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 984N9YTM4Y, chemically known as ketone, 10-(2-(dimethylamino)propyl)phenothiazin-2-yl methyl but generally known as aceprometazine, which bears US NIH Compound Identifier 26035. European Medicines Agency schedules Aceprometazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05214MIG. The term ACEPROMETAZINE is an International Non-Proprietary Name. ACEPROMETAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aceprometazine under HS 29343090 and SITC 51578. As of Q4 2014, ACEPROMETAZINE remains the US FDA Preferred Term for this commodity. Aceprometazine bears US NLM identifiers UMLS ID C0608826 and NCI Concept Code C72678. SMILES: S1c2c(N(CC(N(C)C)C)c3c1cccc3)cc(cc2)C(=O)C.